ABBVIE INC. group: subsidiaries and structure
Corporation · Wilmington, United States · LEI FR5LCKFTG8054YNNRU85
64subsidiaries
37countries
60held directly
43lapsed LEIs
62links on accounts older than 24 months
39ISINs of subsidiaries
Summary
ABBVIE INC. is the ultimate parent of 64 subsidiaries with LEIs in 37 countries, as reported to GLEIF. 60 are held directly; the others sit below intermediate companies. The largest numbers are in the Netherlands (9), in Ireland (7) and in Luxembourg (4). 43 of the subsidiaries have a lapsed LEI, and 62 links rest on accounts older than 24 months. GLEIF's ISIN mapping lists 971 ISINs for the parent and 39 ISINs for its subsidiaries.
Written from GLEIF data using fixed, reviewed sentence templates.
Subsidiaries by country
and 22 more
Data-quality notes (AssetCensus analysis)
No group-level data-quality notes in this data release.
63 subsidiaries have data-quality notes; they are listed on each company page.
Group structure
Indentation shows the direct parent reported to GLEIF.
AbbVie GmbH Austria
ABBVIE PTY LTD Australia
ABBVIE BIOTECHNOLOGY LTD Bermuda
Abbvie Farmaceutica Ltda. Brazil
AbbVie Corporation Canada
Aptalis Pharma Canada ULC Canada
AbbVie Biopharmaceuticals GmbH Switzerland
Pharmacyclics Switzerland GmbH Switzerland
ABBVIE LTD United Kingdom
アッヴィ合同会社 Japan
AbbVie Central Finance B.V. Netherlands
AbbVie Enterprises B.V. Netherlands
AbbVie Finance B.V. Netherlands
AbbVie Logistics B.V. Netherlands
ABBVIE PTE. LTD. Singapore
Subsidiaries
| Company | Country | City | LEI | Accounts year | Notes |
|---|---|---|---|---|---|
| AbbVie GmbH | Austria | Wien | 52990086Q6KA3QYLGR83 | 2024 | |
| ABBVIE PTY LTD | Australia | Sydney | 549300JMBJ4WRPBHQP45 | 2016 | > 24 months |
| ABBVIE BIOTECHNOLOGY LTD | Bermuda | Hamilton | 54930060NJXJDDYP5569 | 2020 | > 24 months |
| AbbVie Finance Limited | Bermuda | Hamilton | 254900YB9XE8MUGBNO17 | 2021 | lapsed > 24 months |
| ABBVIE LTD | Bermuda | Hamilton | 5493006FQ428CLADL324 | 2018 | lapsed > 24 months |
| Abbvie Farmaceutica Ltda. | Brazil | Sao Paulo | 254900SLDR9FRJ2ABN43 | 2020 | > 24 months |
| AbbVie Bahamas Ltd. | Bahamas | Nassau | 549300BDBWUMTO068642 | 2020 | lapsed > 24 months |
| AbbVie Corporation | Canada | Montreal | 549300EZVWWY6FQ2J451 | 2020 | > 24 months |
| Aptalis Pharma Canada ULC | Canada | Calgary | 254900BNZWFX2ZKCBL12 | 2020 | > 24 months |
| AbbVie AG | Switzerland | Cham | 5493004LHR61CWHJ1R71 | 2020 | lapsed > 24 months |
| AbbVie Biopharmaceuticals GmbH | Switzerland | Cham | 5493008JRB6XLN6ZMK73 | 2020 | > 24 months |
| Pharmacyclics Switzerland GmbH | Switzerland | Schaffhausen | 549300M6TKVI4X40BU21 | 2019 | > 24 months |
| 艾伯维医药贸易(上海)有限公司 | China | Shanghai | 254900D139OL0B7KIR57 | 2020 | lapsed > 24 months |
| ABBVIE S.R.O. | Czechia | EVROPSKÁ | 54930083P2R5745DXV78 | 2017 | lapsed > 24 months |
| AbbVie Deutschland GmbH And Co. KG | Germany | Wiesbaden | 549300FI0P3XDOCBXJ78 | 2020 | lapsed > 24 months |
| ABBVIE PRODUCTS GMBH | Germany | WIESBADEN | 549300EJJ80HS1TDLJ16 | 2016 | lapsed > 24 months |
| AbbVie A/S | Denmark | Copenhagen | 5493008LYJEW5J212O93 | 2017 | lapsed > 24 months |
| AbbVie Spain S.L. | Spain | Madrid | 549300TLQK6XFFB81P22 | 2020 | lapsed > 24 months |
| AbbVie Oy | Finland | Espoo | 549300IFW5ZKUU3MX187 | 2017 | lapsed > 24 months |
| ABBVIE SAS | France | RUNGIS | 549300PWLLY08HZKM313 | 2016 | lapsed > 24 months |
| ABBVIE LTD | United Kingdom | Maidenhead | 549300IR197H4S33E479 | 2019 | > 24 months |
| ABBVIE KFT | Hungary | BUDAPEST | 549300VN7D9NXKPU4147 | 2017 | lapsed > 24 months |
| ABBVIE INTERNATIONAL HOLDINGS UNLIMITED COMPANY | Ireland | Dublin | 254900G1ZR5QWOOR9W61 | 2023 | > 24 months |
| ABBVIE IRELAND HOLDINGS LIMITED | Ireland | DUBLIN | 549300WNXDH99N734A82 | 2018 | lapsed > 24 months |
| ABBVIE IRELAND UNLIMITED COMPANY | Ireland | Dublin | 549300UGLN8IS551VC97 | 2020 | lapsed > 24 months |
| ABBVIE LIMITED | Ireland | Dublin | 5493006BTKYVSIO64Z69 | 2020 | lapsed > 24 months |
| ABBVIE MANUFACTURING MANAGEMENT UNLIMITED COMPANY | Ireland | Dublin | 549300W2SNQKMQAVI071 | 2020 | > 24 months |
| Allergan Pharmaceuticals Ireland Unlimited Company | Ireland | Westport | 2549002UGSOFSLSA2L36 | 2020 | > 24 months |
| FOURNIER LABORATORIES IRELAND LIMITED | Ireland | Dublin | 549300EA04TY04J42B85 | 2020 | lapsed > 24 months |
| ABBVIE S.R.L. | Italy | Aprilia | 5493004JIXYSN87UNT74 | 2020 | lapsed > 24 months |
| ABBVIE UK BIOPHARMACEUTICALS LTD | Jersey | ST HELIER | 549300E9JJDLZCA5VK38 | 2016 | lapsed > 24 months |
| アッヴィ合同会社 | Japan | 港区 | 549300WSVEX1QEYQE609 | 2020 | > 24 months |
| AbbVie Limited | South Korea | Seoul | 254900ICOJABG3PWCE35 | 2021 | lapsed > 24 months |
| AbbVie International S.à r.l. | Luxembourg | Luxembourg | 549300DBMP60I6GDGD27 | 2020 | lapsed > 24 months |
| AbbVie Investments S.à r.l. | Luxembourg | Luxembourg | 549300Z3UM6YGMP2QK35 | 2020 | lapsed > 24 months |
| AbbVie Overseas S.à r.l. | Luxembourg | Luxembourg | 549300FSFD23WP1OLS35 | 2016 | lapsed > 24 months |
| AbbVie S.à r.l. | Luxembourg | Luxembourg | 5493005SQ1GOZHBLCW32 | 2018 | lapsed > 24 months |
| ABBVIE FARMACEUTICOS SA DE CV | Mexico | Mexico City | 54930029SNR250CCGY69 | 2020 | > 24 months |
| AbbVie Sdn. Bhd. | Malaysia | Petaling Jaya | 254900H1OK24L9APMY72 | 2021 | lapsed > 24 months |
| AbbVie B.V. | Netherlands | Hoofddorp | 549300WU7MUTNU41H513 | 2020 | lapsed > 24 months |
| AbbVie Central Finance B.V. | Netherlands | Zwolle | 549300QBKQ4EJJK1OY66 | 2018 | > 24 months |
| AbbVie Enterprises B.V. | Netherlands | Zwolle | 254900ZH0XB8NLFALQ62 | 2023 | > 24 months |
| AbbVie Finance B.V. | Netherlands | Zwolle | 549300NTCOV44AP4NH41 | 2020 | > 24 months |
| ABBVIE IRELAND NL B.V. | Netherlands | ZWOLLE | 549300ZNKHBEKHCOHJ43 | 2019 | lapsed > 24 months |
| AbbVie Japan Holdings B.V. | Netherlands | Zwolle | 5493000UZJJD9QOBLU57 | 2020 | lapsed > 24 months |
| AbbVie Logistics B.V. | Netherlands | Zwolle | 549300OZEMSC2H7JBQ56 | 2020 | > 24 months |
| AbbVie Pharmaceuticals B.V. | Netherlands | Zwolle | 54930055MG8WZQYBNR12 | 2020 | lapsed > 24 months |
| ABBVIE RESEARCH B.V. | Netherlands | ZWOLLE | 549300L83K7SALZJEU64 | 2016 | lapsed > 24 months |
| AbbVie AS | Norway | Fornebu | 549300L8C3XRJFYK9H81 | 2018 | lapsed > 24 months |
| ABBVIE LIMITED | New Zealand | AUCKLAND | 54930042FFTY05UQ6587 | 2016 | lapsed > 24 months |
| ABBVIE POLSKA SP. Z O.O. | Poland | WARSAW | 5493002015MYI48FJG19 | 2017 | lapsed > 24 months |
| ABBVIE SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ | Poland | WARSAW | 549300S917ORYBE8TI17 | 2017 | lapsed > 24 months |
| ABBVIE, LDA | Portugal | AMADORA | 5493001U51BIGI75PU38 | 2019 | lapsed > 24 months |
| S.C. ABBVIE S.R.L. | Romania | BUCHAREST | 549300T6B485S3KYZW79 | 2017 | lapsed > 24 months |
| AbbVie Operations Singapore Pte. Ltd. | Singapore | Singapore | 5493007B3KMBWV2BJS13 | 2018 | lapsed > 24 months |
| ABBVIE PTE. LTD. | Singapore | SINGAPORE | 549300BALC1Y8AE7FZ63 | 2016 | > 24 months |
| ABBVIE D.O.O. | Slovenia | LJUBLJANA | 549300SLW6920O7S3I66 | 2017 | lapsed > 24 months |
| ABBVIE S.R.O. | Slovakia | BRATISLAVA | 549300K9TX33PB5O1D93 | 2018 | lapsed > 24 months |
| บริษัท แอ๊บวี่ ฟาร์มาซูติคอลส์ (ประเทศไทย) จำกัด | Thailand | กรุงเทพฯ | 2549005KQD4AIILH4355 | 2019 | > 24 months |
| ABBVIE BIOPHARMACEUTICALS GMBH TAIWAN BRANCH (SWITZERLAND) | Taiwan | Taipei City | 2549001XTJHWN2Q8Y239 | 2021 | > 24 months |
| Abbvie Endocrine Inc. | United States | Wilmington | 549300RITDD6SEJXMP15 | 2016 | lapsed > 24 months |
| AbbVie Foundation | United States | North Chicago | 549300QN7I3K57E52Y66 | 2017 | lapsed > 24 months |
| ALLERGAN, INC. | United States | Wilmington | 6T6CAG8O6TSUTMO6BA21 | 2024 | lapsed |
| AbbVie Pharmaceuticals SCA | Venezuela | Caracas | 549300IKCBHU9QQ4MT03 | 2018 | lapsed > 24 months |